Speaker:
Michael Haffner, MD, PhD, University of Washington, Seattle
At the conclusion of this activity, participants should be able to:
* Understand molecular subtypes of metastatic prostate cancer
* Discuss the spectrum of inter- and intra-tumoral heterogeneity in advanced prostate cancer
* Define rational combination therapies to overcome resistance to targeted therapies
Pathology Grand Rounds